A detailed history of Strs Ohio transactions in Exelixis, Inc. stock. As of the latest transaction made, Strs Ohio holds 67,357 shares of EXEL stock, worth $2.36 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
67,357
Previous 75,445 10.72%
Holding current value
$2.36 Million
Previous $1.7 Million 3.07%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$21.96 - $27.6 $177,612 - $223,228
-8,088 Reduced 10.72%
67,357 $1.75 Million
Q2 2024

Aug 05, 2024

SELL
$20.34 - $23.73 $43,324 - $50,544
-2,130 Reduced 2.75%
75,445 $1.7 Million
Q1 2024

May 13, 2024

SELL
$20.17 - $23.93 $279,798 - $331,956
-13,872 Reduced 15.17%
77,575 $1.84 Million
Q4 2023

Jan 30, 2024

BUY
$19.25 - $24.13 $147,820 - $185,294
7,679 Added 9.17%
91,447 $2.19 Million
Q3 2023

Oct 26, 2023

BUY
$19.04 - $22.74 $1.59 Million - $1.9 Million
83,768 New
83,768 $1.83 Million
Q4 2022

Jan 26, 2023

BUY
$14.96 - $17.39 $280,215 - $325,732
18,731 Added 28.97%
83,396 $1.34 Million
Q3 2022

Oct 27, 2022

SELL
$15.68 - $22.27 $121,833 - $173,037
-7,770 Reduced 10.73%
64,665 $1.01 Million
Q2 2022

Jul 25, 2022

BUY
$17.44 - $23.16 $1.26 Million - $1.68 Million
72,435 New
72,435 $1.51 Million
Q1 2021

Apr 23, 2021

SELL
$20.53 - $25.22 $1.48 Million - $1.82 Million
-72,146 Closed
0 $0
Q4 2020

Jan 25, 2021

BUY
$18.39 - $24.8 $359,027 - $484,170
19,523 Added 37.1%
72,146 $1.45 Million
Q3 2020

Dec 14, 2020

SELL
$20.67 - $26.94 $35,469 - $46,229
-1,716 Reduced 3.16%
52,623 $1.29 Million
Q2 2020

Jul 23, 2020

BUY
$16.46 - $27.42 $458,855 - $764,387
27,877 Added 105.35%
54,339 $1.29 Million
Q1 2020

Apr 23, 2020

BUY
$14.46 - $21.8 $382,640 - $576,871
26,462 New
26,462 $455,000
Q4 2019

Jan 24, 2020

SELL
$15.15 - $18.89 $241,778 - $301,465
-15,959 Closed
0 $0
Q3 2019

Oct 21, 2019

BUY
$17.68 - $22.65 $76,854 - $98,459
4,347 Added 37.44%
15,959 $282,000
Q2 2019

Jul 25, 2019

BUY
$18.93 - $24.75 $61,162 - $79,967
3,231 Added 38.55%
11,612 $248,000
Q1 2019

Apr 19, 2019

BUY
$19.6 - $24.76 $164,267 - $207,513
8,381 New
8,381 $199,000
Q2 2018

Aug 06, 2018

SELL
$18.56 - $22.45 $4.36 Million - $5.28 Million
-235,000 Closed
0 $0
Q4 2017

Jan 23, 2018

BUY
$24.23 - $30.93 $5.69 Million - $7.27 Million
235,000
235,000 $7.14 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.3B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.